Northern Trust Corp Immunity Bio, Inc. Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,323,424 shares of IBRX stock, worth $4.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,323,424

Previous 1,226,076 7.94%

Holding current value

$4.82 Million

Previous $4.55 Million 25.53%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.56 - $6.17 $249,210 - $600,637	97,348 Added 7.94%	1,323,424 $3.39 Million
Q3 2024 Nov 13, 2024	BUY	$3.32 - $6.7 $279,922 - $564,903	84,314 Added 7.38%	1,226,076 $4.55 Million
Q2 2024 Aug 14, 2024	SELL	$4.82 - $9.15 $814,710 - $1.55 Million	-169,027 Reduced 12.9%	1,141,762 $7.22 Million
Q1 2024 May 14, 2024	SELL	$3.23 - $6.17 $149,452 - $285,485	-46,270 Reduced 3.41%	1,310,789 $7.04 Million
Q4 2023 Feb 13, 2024	BUY	$1.25 - $5.21 $255,377 - $1.06 Million	204,302 Added 17.72%	1,357,059 $6.81 Million
Q3 2023 Nov 13, 2023	SELL	$1.29 - $3.1 $11,535 - $27,720	-8,942 Reduced 0.77%	1,152,757 $1.95 Million
Q2 2023 Aug 11, 2023	BUY	$1.53 - $6.41 $535,509 - $2.24 Million	350,006 Added 43.12%	1,161,699 $3.23 Million
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $4,833 - $17,112	-3,580 Reduced 0.44%	811,693 $1.48 Million
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $19,070 - $29,679	4,384 Added 0.54%	815,273 $4.13 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $204,454 - $360,176	56,015 Added 7.42%	810,889 $4.03 Million
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $234,510 - $537,274	87,504 Added 13.11%	754,874 $2.81 Million
Q1 2022 May 13, 2022	SELL	$5.05 - $7.53 $86,642 - $129,192	-17,157 Reduced 2.51%	667,370 $3.75 Million
Q4 2021 Feb 08, 2022	SELL	$5.67 - $10.18 $3.25 Million - $5.84 Million	-573,872 Reduced 45.6%	684,527 $4.16 Million
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $828,014 - $1.29 Million	-90,296 Reduced 6.7%	1,258,399 $12.3 Million
Q2 2021 Aug 13, 2021	BUY	$13.41 - $22.4 $11.6 Million - $19.4 Million	866,888 Added 179.92%	1,348,695 $19.3 Million
Q1 2021 May 12, 2021	BUY	$12.83 - $42.25 $6.18 Million - $20.4 Million	481,807 New	481,807 $11.4 Million

Others Institutions Holding IBRX

# of Institutions

229

Shares Held

82.3M

Call Options Held

1.02M

Put Options Held

2.25M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.46B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Immunity Bio, Inc. Transaction History